A component of the complement system promotes tumor growth by activating myeloid-derived suppressor cells.
References
Markiewski, M.M. et al. Nat. Immunol. 9, 1225–1235 (2008).
Coussens, L.M. & Werb, Z. Nature 420, 860–867 (2002).
Gabrilovich, D.I. et al. Nat. Med. 2, 1096–1103 (1996).
Yang, L. et al. Cancer Cell 6, 409–421 (2004).
Melani, C., Chiodoni, C., Forni, G. & Colombo, M.P. Blood 102, 2138–2145 (2003).
Song, X. et al. J. Immunol. 175, 8200–8208 (2005).
Bunt, S.K. et al. J. Immunol. 176, 284–290 (2006).
Rodriguez, P.C. et al. J. Exp. Med. 202, 931–939 (2005).
Sinha, P., Clements, V.K., Fulton, A.M. & Ostrand-Rosenberg, S. Cancer Res. 67, 4507–4513 (2007).
Sinha, P. et al. J. Immunol. 181, 4666–4675 (2008).
Cheng, P. et al. J. Exp. Med. 205, 2235–2249 (2008).
Gorter, A. & Meri, S. Immunol. Today 20, 576–582 (1999).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ostrand-Rosenberg, S. Cancer and complement. Nat Biotechnol 26, 1348–1349 (2008). https://doi.org/10.1038/nbt1208-1348
Issue Date:
DOI: https://doi.org/10.1038/nbt1208-1348
- Springer Nature America, Inc.
This article is cited by
-
A guide to complement biology, pathology and therapeutic opportunity
Nature Reviews Immunology (2024)
-
Tag SNPs of CFI contributed to the susceptibility for non-small cell lung cancer in Chinese population
Tumor Biology (2015)
-
Tag SNPs in complement receptor-1 contribute to the susceptibility to non-small cell lung cancer
Molecular Cancer (2014)